- Solutions
Applikate Solutions
What they're saying
"Applikate has an excellent team with a breakthrough technology that has the potential to change the world of histopathology." - Company
Company
What they're saying
"Applikate’s new technologies will positively disrupt an entire branch of medical science and business." - Contact
Contact
What they're saying
"Applikate has developed a unique approach to pathology that accelerates diagnosis, eliminates costs, and negates the need for wax embedding and toxic agents. I believe the company will disrupt the field of histology."
Expert Advisors
Investors who share their expertise
A diverse investor group that reflects strong support for a transformative approach to pathology.
20 experts with significant success in medical devices, education, technology-driven entrepreneurship, hardware and software development capitalized the company in 2021. The seed round was oversubscribed, and follows $3.4M in NIH sponsored grants.
$
0
MM
in grants
$
0
MM
in seed funds
$
0
K
in oversubscriptions
0
professional investors
Meet The Team
Select Investors & Advisors
Applikate is backed and supported by investors and advisors carrying a wealth of professional experience and expertise. Not all investors featured here.



